Tag: glaucoma progression despite drops

Why Do I Need Glaucoma Treatment If My Vision Seems Normal?

Glaucoma often causes permanent optic nerve damage long before noticeable vision loss develops. Treatment is designed to protect your future vision by slowing or preventing progression before symptoms appear, Dr Shibal Bhartiya explains.

Your vision feels fine. No pain, no blur, no obvious change. So why is your doctor urging treatment? This is the most common question glaucoma patients ask, and it deserves a direct, honest answer,

Glaucoma destroys your optic nerve silently. By the time you notice something is wrong, you have already lost nerve fibres that will never return. Treatment does not restore what is gone. It protects what remains.

The Vision You Have Now Is Not the Vision You Started With

Glaucoma removes peripheral vision first. Your central vision stays sharp until the disease is advanced. Your brain also compensates, filling in blind areas so skilfully that you do not notice them. You may have lost 30 to 40 percent of your optic nerve fibres before any symptom appears.

This is why “I can see fine” is not a safe reassurance in glaucoma. It reflects the vision that has survived, not the vision that has been lost.

Why Glaucoma Treatment Feels Unnecessary (And Why That Feeling Is Dangerous)

Glaucoma drops do not improve your vision. They do not reduce pain because glaucoma causes none. They do not change how things look today. Their only job is to lower the pressure inside your eye and slow the damage to your optic nerve.

When a treatment produces no felt benefit, stopping it feels harmless. This is the central psychological trap in glaucoma care. Patients who feel well skip doses, delay refills, or discontinue treatment altogether. The nerve continues to deteriorate. By the time symptoms appear, the loss is severe and permanent.

The absence of symptoms is not evidence that you are safe. It is evidence that the disease has not yet crossed your threshold of awareness.

What the Research Actually Shows

Studies consistently show that controlling eye pressure reduces the risk of glaucoma progression. The Ocular Hypertension Treatment Study showed that lowering pressure by 20 percent reduced conversion to glaucoma by more than half. The Early Manifest Glaucoma Trial showed that each mmHg reduction in pressure produced a measurable reduction in progression risk.

You are not treating a feeling. You are treating a measurable biological risk that happens to produce no warning before it causes irreversible harm.

“But My Pressures Are Controlled Now — Do I Still Need Drops?”

Yes. Controlled pressure means the treatment is working. Stopping treatment removes the protection. Pressure typically rises again within days to weeks after discontinuation.

Some patients assume that normal pressure readings mean the problem is resolved. Glaucoma is a chronic condition. Controlled pressure is a maintained state, not a cured one.

Normal-Tension Glaucoma: When Pressure Is Not Even the Full Story

A significant group of patients develop glaucoma with eye pressures in the statistically normal range. Their optic nerves are still vulnerable, often due to poor blood flow, structural susceptibility, or other factors. For these patients, the question “but my pressure is fine” does not mean treatment is unnecessary. It means the target pressure needs to be set lower, and other risk factors need attention.

This is one reason that glaucoma management requires individual assessment, not a one-size guideline.

FAQ

If I have no symptoms, does that mean my glaucoma is mild?

Not necessarily. Glaucoma can cause significant optic nerve damage before any symptom appears. The severity of glaucoma is assessed through structural tests like OCT and functional tests like visual fields, not through how your vision feels day to day.

What happens if I skip my glaucoma drops for a few days?

Eye pressure can rise within 24 to 48 hours of stopping treatment. Over time, this pressure exposure adds to cumulative nerve damage. Occasional missed doses are less harmful than long gaps, but no dose-skipping is risk-free in active glaucoma.

Can I know if my glaucoma is getting worse?

Progression is detected through serial OCT scans and visual field testing, not through symptoms. This is why regular follow-up is essential even when your vision feels unchanged.

My doctor wants to change my drops. Should I get a second opinion first?

A second opinion is always appropriate in glaucoma, especially if you are uncertain about treatment changes, surgical recommendations, or whether your current regimen is adequate. Glaucoma causes irreversible loss, so the cost of a wrong decision is permanent.

Are there people who do not need treatment despite a glaucoma diagnosis?

In very early suspected glaucoma or ocular hypertension with low risk factors, observation may be appropriate rather than immediate treatment. This is a clinical judgement based on your individual risk profile, your optic nerve appearance, and your visual field results. It requires an experienced glaucoma specialist to make that call correctly.

What You Should Expect From Your Glaucoma Care

A good glaucoma consultation does more than prescribe drops. It establishes your target pressure based on your stage of disease, your age, and your life expectancy. Also, it identifies your progression rate through serial testing. It reviews whether your current treatment is achieving that target. And it explains, clearly, what is at stake if treatment is inconsistent.

If you have left a consultation without understanding why your specific pressure target was chosen, that is worth asking about. If you are uncertain whether your glaucoma is stable or progressing, that is worth investigating through formal visual field and OCT trend analysis.

A Note on Seeking a Second Opinion

Glaucoma decisions carry permanent consequences. Second opinions are not a sign of distrust toward your current doctor. They are a rational response to a disease where the cost of under-treatment is irreversible. An independent review of your scans and pressure history can confirm that you are on the right path, or catch something that has been missed.

This page is part of the Glaucoma Hub hub. Read about our full approach to glaucoma care. Please also read our Second Opinion Hub. Please also read Glaucoma Diagnosis, first 90 days; and Glaucoma Treatment

Here’s another heartening patient story: Tired of drops

About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google

Glaucoma Care in Gurgaon

Glaucoma is the leading cause of irreversible blindness worldwide. It is a progressive optic nerve disease that can silently damage vision much before symptoms become obvious. Early diagnosis, OCT imaging, visual field testing, and long-term monitoring are essential to reducing the risk of irreversible vision loss.

Superspecialty glaucoma care means catching that damage early, tracking it precisely, and making treatment decisions that are built around your individual risk, not a standard protocol.

Glaucoma Care in Gurgaon: Diagnosis, Treatment, and Second Opinions

Most people who arrive at a glaucoma consultation did not expect to be there.

Perhaps a routine eye check flagged your optic nerve. Maybe a parent lost vision to glaucoma and you want to know your own risk. Perhaps you have been on drops for years and something still doesn’t feel right. Whatever brought you here, you are asking the right question at the right time, because in glaucoma, timing is everything.

The nerve fibres that glaucoma destroys do not regenerate. Vision lost to this disease does not return. But vision that has not yet been lost can almost always be protected, if the disease is identified accurately, monitored carefully, and managed by a specialist with the training to interpret what the tests are actually showing.

This is what superspecialty glaucoma care means in practice.

What Glaucoma Actually Is

Glaucoma is not a single disease. It is a family of conditions that share one defining feature: progressive damage to the optic nerve, the cable that carries visual information from your eye to your brain.

In most forms of glaucoma, elevated intraocular pressure — the fluid pressure inside the eye — is the primary driver of that damage. But pressure is not the whole story. Roughly a third of glaucoma patients have pressures that fall within the normal range. In these patients, the nerve is vulnerable for reasons that go beyond simple mechanics — vascular supply, structural anatomy, and systemic factors all play a role.

This is why glaucoma cannot be managed by pressure alone. It requires a trained eye on the nerve itself.

The most common forms of glaucoma

Primary open-angle glaucoma is the most prevalent form globally and in India. It develops slowly, painlessly, and without warning. By the time peripheral vision is affected, significant nerve damage has usually already occurred.

Normal tension glaucoma is systematically underdiagnosed in India. Patients with pressures in the normal range are often reassured and discharged — while damage continues. Identifying this condition requires looking beyond the pressure reading.

Angle-closure glaucoma is more common in Asian populations. It can present as a sudden, painful emergency — or develop slowly and silently in the chronic form. A detailed anterior segment assessment is essential to detect the anatomical risk before a crisis occurs.

Childhood and secondary glaucomas require specialist evaluation. Secondary glaucomas — arising from inflammation, steroid use, trauma, or systemic conditions — are frequently missed or mismanaged without subspecialty input.

Why Superspecialty Training Changes Outcomes

A general ophthalmologist is trained to detect glaucoma and initiate treatment. A fellowship-trained glaucoma subspecialist is trained to do something more precise: to distinguish true progression from test variability, to select the right intervention at the right disease stage, and to manage the full complexity of a condition that evolves over decades.

The difference becomes most visible in three situations.

When the diagnosis is uncertain. Glaucoma suspects — patients with suspicious optic nerves or borderline pressures who do not yet meet diagnostic criteria — require careful longitudinal monitoring. The decision of when to treat, and how aggressively, requires experienced clinical judgement.

When progression occurs despite treatment. Patients who worsen on drops are not simply non-compliant. They may have nocturnal pressure spikes, inadequate pressure targets, or structural vulnerability that requires a different therapeutic approach entirely.

When surgery is on the table. The glaucoma surgical landscape has changed significantly with the advent of MIGS — minimally invasive glaucoma surgery. Knowing when MIGS is appropriate, which device fits which patient, and when conventional filtration surgery remains the better option requires a surgeon who operates across the full spectrum.

What to Expect at This Practice

My approach to glaucoma care is built around four principles.

Catch it before it matters. Early detection requires looking beyond the standard pressure check — at the optic nerve structure, the retinal nerve fibre layer on OCT, and the visual field pattern over time. I look for the signal before the symptom.

Track it with precision. A single test is a photograph. Glaucoma management requires a series of photographs — read by someone who understands what change looks like, and what normal variation looks like. I review trends, not snapshots.

Treat it at the right stage. Not every glaucoma patient needs surgery. Not every glaucoma patient can be managed on drops alone. The treatment plan is built around your disease stage, your lifestyle, your pressure target, and your individual risk of progression.

Protect the ocular surface. Long-term glaucoma drops affect the surface of the eye in a significant proportion of patients. Ocular surface disease reduces comfort, affects adherence, and is frequently undertreated. I address it as part of glaucoma management — not as a separate problem.

Glaucoma Care Covered in This Practice

Diagnosis and Detection

Medical Management

Monitoring and Progression

Surgery

Local and General

When to Come In

Book a superspecialty consultation if any of the following apply:

  • You have been told your optic nerve looks “suspicious” or “cupped”
  • You have a parent or sibling with glaucoma
  • You are on glaucoma drops and have never had a formal progression assessment
  • Your visual fields are worsening despite treatment
  • You have been recommended surgery and want a second opinion
  • You have high myopia — a significant independent risk factor for glaucoma
  • You use steroid drops, inhalers, or nasal sprays regularly

Glaucoma does not announce itself. By the time you notice something is wrong, the window for easy intervention may already be narrowing. Early assessment costs very little. Late diagnosis costs vision.

Frequently Asked Questions

What is the difference between a glaucoma specialist and a general eye doctor?

A glaucoma specialist has completed a dedicated fellowship — one to two years of focused training in glaucoma diagnosis, medical management, laser, and surgery — beyond standard ophthalmology residency. This training matters most in uncertain diagnoses, complex progression, and surgical planning.

How often should I have my eyes checked if I have glaucoma?

Most patients with established glaucoma require review every three to six months, including IOP measurement, OCT, and periodic visual field testing. The exact frequency depends on your disease stage, stability, and treatment response. Suspects require annual or biannual monitoring.

Can glaucoma be cured?

Glaucoma cannot currently be cured — but in the vast majority of patients, it can be controlled well enough to preserve functional vision for life. The key is early detection, accurate monitoring, and treatment that is adjusted as the disease evolves.

Is glaucoma hereditary?

Yes. First-degree relatives of glaucoma patients have a four to nine times higher risk of developing the condition. Screening siblings and adult children of affected patients is one of the most cost-effective interventions in glaucoma prevention.

What is MIGS and am I a candidate?

MIGS — minimally invasive glaucoma surgery — is a family of procedures designed to lower eye pressure with a safer profile than traditional filtration surgery. It is most appropriate for mild to moderate glaucoma. Not every patient is a candidate; appropriate selection requires subspecialty assessment.

You may want to listen to Dr Bhartiya answer some frequently asked questions here.

About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation for glaucoma

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google

Here are some patient stories

The English Teacher Who Began Painting Again

How to do visual fields

Uveitic glaucoma

Advanced Glaucoma Care in Gurgaon

Looking for advanced glaucoma care in Gurgaon? Dr Shibal Bhartiya provides expert diagnosis, risk stratification, second opinions, and long-term glaucoma management focused on preserving vision safely over time. Glaucoma can progress silently even when vision feels normal. Advanced glaucoma care combines detailed testing, risk stratification, continuity of follow-up, and individualized treatment planning to reduce the risk of preventable vision loss.

Advanced glaucoma care in Gurgaon requires more than a pressure check and a prescription. It requires structural analysis, individualised progression mapping, and a specialist with the training to catch damage before your vision notices it. That specialist should have fellowship-level expertise -not just general ophthalmology experience.

Most patients arrive at a glaucoma consultation after one of two experiences: a routine eye test that flagged something unexpected, or months of treatment that doesn’t feel like it’s working. Both are disorienting. Glaucoma is a condition where the stakes are permanent, lost nerve fibres do not return, and yet most early-stage patients feel completely normal. That gap between invisibility and irreversibility is exactly why the quality of your specialist matters more than in almost any other eye condition.

This page is not a list of credentials. It is a plain-language explanation of what advanced glaucoma management actually involves, so you can ask the right questions, in any clinic, including mine.

What Makes Glaucoma Management Genuinely Complex

Glaucoma is not one disease. It is a family of conditions: each with different pressure profiles, different structural signatures, and different rates of progression. Managing it well requires training that goes beyond what a general ophthalmologist receives.

Pressure is necessary, but not sufficient

Intraocular pressure (IOP) is the most controllable risk factor in glaucoma. But roughly 30–40% of glaucoma patients in India have pressures that fall within the “normal” range. A specialist who treats only the number, and misses the nerve, will miss the disease.

Structural progression requires trained interpretation

OCT (optical coherence tomography) scans generate data that is only as useful as the clinician reading it. Retinal nerve fibre layer thinning, ganglion cell loss, and optic disc changes must be interpreted in the context of your age, disc anatomy, and longitudinal trend. A single scan means very little. A series of scans, read by someone who knows what they are looking for, means everything.

24-hour IOP behaviour matters

IOP fluctuates across the day and night. A single clinic reading captures one moment. Fellowship-trained glaucoma specialists are trained to account for diurnal variation, peak pressure timing, and nocturnal dips: factors that can determine whether a patient progresses despite apparently controlled pressures. This is an area where I have published peer-reviewed research.

Treatment decisions are not linear

Drops, laser, MIGS (minimally invasive glaucoma surgery), and filtration surgery each have a specific place in a well-structured management plan. Choosing the right intervention, and the right sequence, requires experience with the full treatment spectrum, not just the tools a particular clinic happens to offer.

What to Look For When Choosing a Glaucoma Specialist in Gurgaon

This is the question most patients search for but rarely find answered honestly. Here is what actually differentiates a glaucoma subspecialist from a general eye doctor offering glaucoma care.

What to AskWhy It MattersWhat to Look For
Did the doctor complete a glaucoma fellowship?Fellowship training means 1–2 years of dedicated subspecialty immersion beyond residencyLook for fellowship credentials, not just MBBS + MS
Does the clinic offer 24-hour IOP monitoring?Single readings miss nocturnal pressure spikes that drive progressionAsk whether phasing or ambulatory IOP is available
Can the doctor interpret OCT trends across time?Structural progression is subtle and cumulativeAsk how many scans are needed before they track trends
Is MIGS offered — and appropriately selected?MIGS is not appropriate for every patient; over-recommendation is a red flagA good specialist will tell you when surgery is not yet needed
Does the specialist publish research?Research engagement means currency with evolving evidenceCheck PubMed, ORCID, or academic profiles

What Doctors Often Miss in Glaucoma Consultations

In over 25 years of glaucoma practice, these are the patterns I see most often in patients who arrive for a second opinion.

Normal pressure, missed diagnosis. Normal tension glaucoma is systematically underdiagnosed in India. Patients with pressures of 14–16 mmHg are reassured and discharged — while nerve fibre loss continues silently.

OCT reported as “stable” without longitudinal comparison. A single OCT is a photograph. Stability can only be determined by comparing photographs across time. Patients are sometimes told they are stable after one scan.

Ocular surface disease from drops, untreated. Long-term use of preserved glaucoma drops causes surface inflammation in a significant proportion of patients. This is rarely addressed proactively — and yet it affects adherence, comfort, and outcomes directly.

MIGS offered too early or too late. Minimally invasive glaucoma surgery has transformed the moderate-stage treatment window. But it is not a substitute for medical therapy in early disease, and it is insufficient for advanced disease. Appropriate patient selection is a subspecialty skill.

Family history not taken seriously. First-degree relatives of glaucoma patients have a 4–9x elevated risk. Screening of siblings and children is rarely initiated proactively.

When to Seek a Second Opinion

Seek a second opinion if any of the following apply:

  • You have been on the same drops for more than two years with no formal progression assessment
  • Your visual field tests show worsening despite treatment
  • You were told your pressures are normal but your optic nerve looks “suspicious”
  • Surgery has been recommended and you want to understand all your options
  • You have a strong family history and want a baseline assessment from a subspecialist

A second opinion is not disloyalty to your current doctor. In a condition where the damage is permanent and irreversible, it is due diligence.

What This Means for You

If you are searching for the best glaucoma care in Gurgaon, the most important thing you can do is not look for a superlative — it is to look for a subspecialist. Fellowship training, peer-reviewed research, and a structured approach to progression monitoring are the markers that distinguish subspecialty glaucoma care from general ophthalmology practice.

I am a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience managing glaucoma across its full spectrum — from early suspect to advanced disease requiring surgical intervention. My practice at Marengo Asia Hospitals, Sector 56, Gurugram is built around catching damage before it becomes irreversible, and around ensuring that every treatment decision is grounded in your individual risk profile — not a protocol.

If you would like a structured assessment or a second opinion on your current management, I am available for consultation.

📞 +91 88826 38735 | 🌐 www.drshibalbhartiya.com

Frequently Asked Questions

How do I choose the best glaucoma specialist in Gurgaon?

Look for a doctor who completed a dedicated glaucoma fellowship — not just general ophthalmology training. The best glaucoma specialists offer structural progression monitoring with OCT, account for 24-hour pressure behaviour, and have experience across the full treatment spectrum including MIGS and filtration surgery. Research publications are a reliable indicator of subspecialty currency.

What is the difference between a glaucoma specialist and a general eye doctor?

A glaucoma specialist has completed additional fellowship training — typically one to two years — focused exclusively on glaucoma diagnosis, medical management, laser, and surgery. A general ophthalmologist can manage straightforward cases but may lack the training to detect subtle progression, interpret complex OCT trends, or select patients appropriately for MIGS.

Is Dr Shibal Bhartiya the best glaucoma doctor in Gurgaon?

Dr Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience and 90+ PubMed-indexed publications. She offers subspecialty glaucoma care including second opinions, advanced surgical options including MIGS, and 24-hour IOP assessment at Marengo Asia Hospitals, Sector 56, Gurugram. Patients are encouraged to review her published research and make their own assessment.

What should I look for when seeking the best doctor for MIGS surgery in Gurgaon?

MIGS, minimally invasive glaucoma surgery, requires a surgeon with specific training in device selection, patient eligibility assessment, and intraoperative technique. Ask whether your surgeon has published on MIGS outcomes, can explain why you are or are not a candidate, and offers filtration surgery as an alternative if MIGS is insufficient for your disease stage.

Can I get a glaucoma second opinion in Gurgaon?

Yes. Second opinions for glaucoma are available at Marengo Asia Hospitals, Sector 56, Gurugram. Bring your previous OCT scans, visual field reports, and current prescription to your appointment. A structured second opinion typically includes a full structural assessment, pressure evaluation, and review of your current management plan.

About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation for glaucoma

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google

More Glaucoma Eye Drops is Not Better Glaucoma Care

Posted on by Dr Shibal Bhartiya

More glaucoma eye drops do not guarantee better control. Treatment must be individualised based on risk, progression, and tolerance. Overmedication…

Steroid Induced Glaucoma

Posted on by Dr Shibal Bhartiya

Steroids carry a risk that many patients, and even some prescribing doctors, overlook. They can silently raise the pressure inside…